{
  "nct_id": "NCT96952461",
  "indication": "Epilepsy",
  "phase": "Phase 1",
  "sample_size": 412,
  "duration_weeks": 55,
  "dropout_rate": 0.15,
  "primary_endpoints": [
    "Quality of life"
  ],
  "secondary_endpoints": [
    "Seizure frequency",
    "Seizure-free days"
  ],
  "blinding": "double-blind",
  "control_arm": "placebo",
  "outcome_summary": "Study met its primary endpoint with Quality of life showing statistically significant improvement.",
  "success": true,
  "failure_reason": ""
}